In Conversation

Let’s start by introducing our readers to the Austrian affiliate of Cegedim. Can you summarize Cegedim scope of activities and operations in Austria, as well as…

In your opinion, what have been the most important developments of the healthcare market in Austria over the last three years? To start with, even though…

“ Mr. Cooke, you joined Alkermes after the company acquired the Elan Drug Technologies (EDT) unit in 2011—a unit you headed for four years. Can you please… ”
“ Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? ”

Mylan embarked upon its first major international expansion program in 2007, after the acquisition of Merck KGaA’s generic medicines business. How has the organization subsequently evolved…

In three months you will be celebrating two years as the head of Takeda Colombia. Your two major objectives were to set up the Andean cluster…

“ Mr. Keogh, you founded Millmount Healthcare in 1999. What was the vision behind the company? ”

One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What were the strategic motivations…

You have been with Grünenthal since 2004 and as the Austria Country Manager since June 2012. What were your initial goals when you took up the…

Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player…

As a means of introduction, could you please describe the origins of ALDIMED, how it started, its development the past couple of years and where it…

You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here